91051-3
Methamphetamine+Methylenedioxymethamphetamine [Presence] in Tissue by Screen method
Active
Part Descriptions
LP269521-3 Methamphetamine+Methylenedioxymethamphetamine
Methylenedioxymethamphetamine (MDMA) (3,4-methylenedioxymethamphetamine) is an empathogenic drug of the phenethylamine and amphetamine classes of drugs. Amphetamines and phenethylamines are a class of chemicals/drugs that are synthetic, psychoactive drugs. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation. In 1985, the US Drug Enforcement Administration moved the drug to Schedule 1 status with no accepted medical use.
Source: Regenstrief LOINC, MDMA
LP269521-3 Methamphetamine+Methylenedioxymethamphetamine
Methamphetamine (MA) is a drug of abuse also referred to as meth, crystal and speed. It is a central nervous system stimulant that can be injected, smoked, snorted or ingested. Short-term MA abuse causes an increase of energy, sense of well-being and decreased appetite that lasts 6-8 hours. PMID: 19042205 MA use can lead to stroke, cardiac arrhythmia, stomach cramps, shaking, anxiety, insomnia, paranoia, hallucinations, and structural changes to the brain. Pregnant women who use MA can cause growth retardation, premature birth, and developmental disorders in neonates and long lasting intellectual deficits to the children as they grow. PMID: 10908000 Users addicted to MA experience withdrawal symptoms that include dysphoria, fatigue, insomnia and an increased appetite. In chronic MA users positron emission tomography has proven a decrease in dopamine D2 receptors which is associated with mental deterioration that can be reversed to some extent after abstaining from MA. PMID: 19042205
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- Methamphetamine+Methylenedioxymethamphetamine
- Property
- PrThr
- Time
- Pt
- System
- Tiss
- Scale
- Ord
- Method
- Screen
Additional Names
- Short Name
- Methamphet+MDMA Tiss Ql Scn
- Display Name
- Methamphetamine+MDMA Screen Ql (Tiss)
- Consumer Name Alpha Get Info
- Methamphetamine+MDMA, Tissue
Example Answer List: LL2355-7
Source: Laboratory Corporation of AmericaAnswer | Code | Score | Answer ID |
---|---|---|---|
PositiveCopyright http://snomed.info/sct ID:10828004 Positive (qualifier value) | LA6576-8 | ||
None detected | LA19544-8 |
Basic Attributes
- Class
- DRUG/TOX
- Type
- Laboratory
- First Released
- Version 2.65
- Last Updated
- Version 2.65
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
91055-4 | Drugs of abuse panel - Tissue |
Member of these Groups Get Info
LOINC Group | Group Name |
---|---|
LG50150-8 | Methamphetamine+Methylenedioxymethamphetamine| |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Metanfetamina + Metilendioximetanfetamina: |
es-MX | Spanish (Mexico) | Metanfetamina + Metilendioximetanfetamina: |
fr-FR | French (France) | Methamphétamine+méthylènedioxymethamphétamine: |
it-IT | Italian (Italy) | Metanfetamina+Metilenediossimetanfetamina: Synonyms: Livelli farmacologici e tossicologia Presenza o Soglia Punto nel tempo (episodio) Screening tossicologico Tessuto & |
zh-CN | Chinese (China) | 甲基苯丙胺+亚甲基二氧甲基苯丙胺: Synonyms: C10H15N; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=91051-3
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright